SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001144204-15-059133
Filing Date
2015-10-13
Accepted
2015-10-13 12:25:05
Documents
10

Document Format Files

Seq Description Document Type Size
1 POS AM v421993_posam.htm POS AM 1089422
2 EXHIBIT 5.1 v421993_ex5-1.htm EX-5.1 12552
3 EXHIBIT 23.2 v421993_ex23-2.htm EX-23.2 2722
4 GRAPHIC tpg4.jpg GRAPHIC 7119
  Complete submission text file 0001144204-15-059133.txt   5400915

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT antb-20150630.xml EX-101.INS 883951
6 XBRL TAXONOMY EXTENSION SCHEMA antb-20150630.xsd EX-101.SCH 56664
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20150630_cal.xml EX-101.CAL 50871
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20150630_def.xml EX-101.DEF 354626
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20150630_lab.xml EX-101.LAB 416317
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20150630_pre.xml EX-101.PRE 402301
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-196093 | Film No.: 151155427
SIC: 2834 Pharmaceutical Preparations